{"id":2662,"date":"2020-09-30T20:20:44","date_gmt":"2020-09-30T20:20:44","guid":{"rendered":"https:\/\/alshahba-pharma.com\/?p=2662"},"modified":"2020-09-30T20:21:10","modified_gmt":"2020-09-30T20:21:10","slug":"neodergin","status":"publish","type":"post","link":"https:\/\/alshahba-pharma.com\/en\/2020\/09\/30\/neodergin\/","title":{"rendered":"Neodergin"},"content":{"rendered":"

Neodergin<\/h2><\/div>

Composition:<\/u><\/strong><\/p>\n

Oral drops: Each 1ml (30 drops) contains 1mg Ergoloid mesylates.<\/p>\n

Indications: <\/u><\/strong><\/p>\n

A proportion of individuals over 60 who manifest signs and symptoms of an idiopathic decline in mental capacity (i.e., cognitive and interpersonal skills, mood, self-care, apparent motivation) can experience some symptomatic relief upon treatment with ergoloid mesylates preparations.<\/p>\n

It appears, however, that those individuals who do respond come from groups of patients who would be considered clinically to suffer from some ill-defined process related to aging or to have some underlying dementing condition (i.e., primary progressive dementia, Alzheimer’s dementia, senile onset, multi-infarct dementia).<\/p>\n

Ergoloid mesylates preparations are not indicated in the treatment of acute or chronic psychosis.<\/p>\n

Dosage:<\/u><\/strong><\/p>\n

1 mg three times a day.<\/p>\n

Alleviation of symptoms is usually gradual and results may not be observed for 3-4 weeks.<\/p>\n

Package:<\/u><\/strong><\/p>\n

Oral drops: Bottle of 30ml.<\/p>\n<\/div>

<\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2663,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[101,41,82,65,38],"tags":[],"class_list":["post-2662","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicines","category-neurological-drugs","category-oral-drops","category-pharmacologic-form","category-therapeutic-categories"],"_links":{"self":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts\/2662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=2662"}],"version-history":[{"count":1,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts\/2662\/revisions"}],"predecessor-version":[{"id":2665,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts\/2662\/revisions\/2665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/media\/2663"}],"wp:attachment":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=2662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=2662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=2662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}